Friday, November 19, 2010
West Virginia Supreme Court Reverses Ruling Against Johnson & Johnson
WEST VIRGINIA....
The West Virginia Supreme Court has reversed a ruling and nearly $4.5 million penalty against drugmaker Johnson & Johnson, ruling that a lower court erred when it did not allow Johnson & Johnson to defend itself against evidence after federal authorities said its literature regarding two drugs was false or misleading. The U.S. Food and Drug Administration had twice warned the company that brochures on its narcotic pain patch Duragesic contained false or misleading statements. A Brook County Circuit judge also ruled the company's November 2003 letter on schizophrenia drug Risperdal intentionally modified the FDA's warning language and misled healthcare professionals.
The West Virginia Supreme Court has reversed a ruling and nearly $4.5 million penalty against drugmaker Johnson & Johnson, ruling that a lower court erred when it did not allow Johnson & Johnson to defend itself against evidence after federal authorities said its literature regarding two drugs was false or misleading. The U.S. Food and Drug Administration had twice warned the company that brochures on its narcotic pain patch Duragesic contained false or misleading statements. A Brook County Circuit judge also ruled the company's November 2003 letter on schizophrenia drug Risperdal intentionally modified the FDA's warning language and misled healthcare professionals.